Aim: Activating transcription factor 6 (ATF6) is a key signal transducer of endoplasmic reticulum stress (ER stress). This study was conducted to clarify the potential role of ATF6 in the insulin signaling pathway under chronic ER stress. Methods: ER stress of HEK293 cells was induced with tunicamycin (2 µg/mL). The cells were transfected with ATF6α or ATF6β. The phosphorylation level of insulin receptor (IR) was analyzed using Western blot. The changes in ER stress and ERK signaling pathways were explored using Western blot and quantitative real-time PCR. Results: Tunicamycin-induced chronic ER stress attenuated IR tyrosine phosphorylation in a time-dependent manner, whereas overexpression of ATF6 protected IR from desensitization. ATF6 modulation of IR suppression was associated with insulin-stimulated extracellular signal-regulated kinase (ERK) phosphorylation. The treatment of the cells with a specific ERK inhibitor U0126 (10 µmol/L) mimicked the effect of ATF6 over-expression and restored the insulin-stimulated IR phosphorylation. The treatment of the cells with the ERK activator epidermal growth factor (EGF, 200 ng/mL) decreased the protection effect of ATF6 on IR.
Introduction
Type 2 diabetes is a severe threat to worldwide public health. Its main features include relative insulin deficiency, insulin resistance and hyperglycemia [1] . Over the past few years, tremendous progress has been made in elucidating the molecular mechanisms involved in the origin and development of insulin resistance, although many gaps still remain to be filled.
The endoplasmic reticulum (ER) is an organelle where protein folding, post-translational modification and oligomerization take place. This reticulum system senses alterations of intracellular homeostasis provoked by stimuli, subsequently inducing an unfolded protein response (UPR) [2] . The UPR decreases protein translation, increases chaperone expression and accelerates the degradation of misfolded proteins via three main signal transducers to alleviate cellular stress and restore ER homeostasis. These transducers include inositol-requiring enzyme-1α (IRE-1α), PKR-like ER kinase (PERK), and activating transcription factor 6 (ATF6). When ER stress fails to be attenuated, apoptosis will be activated and cells are subjected to chronic stimulation [2] . Recently, there has been a special interest in ER stress because of its central role in the pathogenesis of type 2 diabetes, and valuable results have been discovered [3] [4] [5] [6] . For example, it was found that molecular indicators of ER stress, such as PERK, eukaryotic initiation factor 2α (eIF2α) and glucoseregulated protein 78 (GRP78), increased in liver and adipose tissues of dietary and genetic murine obesity models. In addition, administration of tunicamycin, an ER stress inducer, results in suppression of insulin receptor signaling (insulin receptor substrate 1 (IRS-1) tyrosine and AKT serine phosActivating transcription factor 6 protects insulin receptor from ER stress-stimulated desensitization via p42/44 ERK pathway [3] . ER stress was also discovered to repress the insulin signaling pathway through activation of the IRE-1α and c-Jun N-terminal kinase (JNK) pathways [3, 7, 8] . Over-expression of X-box binding protein 1 (XBP-1), another important ER stress signal transducer, down-regulates JNK activity, enhances insulin receptor signaling pathway activity and restores glucose homeostasis [3] . The attenuation of ER stress by chemical chaperone [eg, 4-phenyl butyric acid (PBA) and taurine-conjugated derivative (TUDCA)] treatment or oxygen-regulated protein 150 kDa (Orp150) over-expression has been confirmed effective in increasing insulin sensitivity and ameliorating diabetes in vivo [4] [5] [6] . Although targeting ER stress has been hinted at as a promising therapeutic strategy for anti-diabetic agent discovery, further investigations should remain in consideration of the complexity of the ER stress network.
Activating transcription factor 6 (ATF6) is a 90-kDa ERanchoring protein with cytoplasmic and transmembrane domains. The cytoplasmic domain contains a transcriptional activation domain (TAD) and a b-ZIP DNA binding motif [9, 10] . Two isoforms of ATF6 have been determined to date, ATF6α and ATF6β. Although the N-terminals of these two isoforms share conserved b-ZIP domains, ATF6α and ATF6β differ greatly in their transcriptional abilities. This is because of their dissimilar transcriptional activation domains [11] , which leads to different functions on target genes [12, 13] . When unfolded proteins accumulate in the ER by chemical stimulation or in physiopathological conditions [14, 15] , ATF6 is released from the ER lumen by sequential cleavage of Site 1 (S1P) and Site 2 proteases (S2P) [9] . This produces a 50-kDa fragment that moves to the nucleus to activate chaperone genes, such as GRP78, GRP94 and protein disulfide isomerase (PDI), thus ameliorating ER stress [16] . Regarding the potent involvement of ER stress in the pathogenesis of type 2 diabetes [17] [18] [19] and the determined function of ATF6 in the management of cell homeostasis [15, 16] , we attempted to clarify the potential role of ATF6 in the insulin signaling pathway. We discovered that both ATF6α and ATF6β attenuate tunicamycin stimulated IR desensitization through an ERK-related pathway. It is expected that members of the ATF6 family could be potential therapeutic targets for anti-obesity and type 2 diabetes drug discovery.
Materials and methods

Materials
Restriction enzymes were purchased from New England Biolabs, NJ, USA. Cell culture plastic ware was from Corning Inc, MA, USA. DMEM culture medium and fetal bovine serum were from Invitrogen, CA, USA. Tunicamycin, insulin, epidermal growth factor, U0126, MTT [3-(4,5-dimethyl-2-yl)-2,5-diphenyl tetrazolium bromide] and SB203580 were obtained from Sigma, USA. RNAiso, RT reagent Kit and SYRB Premix Ex Taq were purchased from TaKaRa, Japan. Anti-ATF6α (full and cleavage) antibody was from Imgenex Corp, San Diego, USA. Anti-IR, anti-phospho-IGF-I receptor β (Tyr1135/1136)/ insulin receptor β (Tyr1150/1151), anti-AKT, anti-phospho-AKT (Ser473), anti-p44/42 Erk1/2, anti-phospho-p44/42 Erk1/2 (Thr202/Tyr204), anti-SAPK/JNK, anti-phospho-SAPK/JNK (Thr183/Tyr185), anti-p38 MAPK, anti-phosphop38 MAPK (Thr180/Tyr182), anti-GRP78/Bip, anti-GAPDH, anti-eIF2α-pSer51 and anti-IRE1α-pSer74 antibodies were purchased from Cell Signaling Technology, MA, USA. Plasmids pcDNA3.1-hATF6α and β were kindly provided by Prof Kazutoshi MORI (Department of Biophysics, Graduate School of Science, Kyoto University, Kyoto, Japan).
Plasmid constructs
ATF6α and ATF6β genes were amplified by Pfu polymerase (Tiangen) from the plasmids pcDNA3.1-hATF6α and pcDNA3.1-hATF6β. The genes were then ligated into Xho I/ Hind III-digested and Xho I/EcoR I-digested pEYFP-C1 vectors, respectively.
Stable transfection
HEK293 cells were plated into 3.5 cm plates and transfected with 3 µg pEYFP-C1/pEYFP-C1-hATF6α/pEYFP-C1-hATF6β by using 8 µL Lipofectamine™ 2000 (Invitrogen Inc, California, USA). Medium was changed after 5 h. On the next day, cells were harvested and plated into 10-cm plates in the ratio of 1:400 and incubated in 10% DMEM/FBS. Medium was refreshed every 2 d. After 2 weeks, resistant foci of clones were selected, verified and maintained for further study.
Western blot analysis
Supernatants of the whole cell extracts were fractionated by SDS-PAGE and transferred to Hybond-c nitrocellulose membrane (Amersham Bioscience, Sweden). The membranes were blocked for 1 h at room temperature and then incubated overnight at 4 °C in TBST buffer (5% milk) containing antibody. On the next day, the membranes were incubated for an hour at room temperature in TBST buffer (5% milk) containing antirabbit IgG or anti-mouse IgG (Jackson-ImmunoResearch, West Grove, PA, USA). Blots were visualized by incubation with SuperSignal West Dura chemiluminescence kit (Pierce Biotechnology, Rockford, USA) and exposed to light-sensitive film. The experiments were performed in triplicate, and bands were quantified using Image-Pro Plus software and statistically analyzed. Each band was calculated as "intensity×area" using the Image-Pro Plus software (MediaCybernetics, Micromecanique, France). SD was calculated from the three replications of the experiment.
RNA preparation and quantitative real-time PCR Total RNA was extracted from transiently transfected HEK293 cells or stable cell lines (6-well) using RNAiso (TaKaRa, Japan) reagent according to the kit instruction. Complementary DNA was synthesized using an RT reagent kit (TaKaRa, Japan). Real-time PCR was performed using SYBR Premix Ex Taq (TaKaRa, Japan) on DNA Engene Opticon TM 2 System (MJ Research, Waltham, MA, USA). The PCR cycle was 95 °C for 10 s, 58 °C for 45 s, and 72 °C for 30 s. The primers are listed in Table 1 . 
Statistical analysis
All data are shown as mean±standard deviation (SD). Data were analyzed using either a one-way ANOVA with an appropriate post hoc test comparison of multiple groups or an unpaired student's t test for comparison of two groups as described in the figure legends (Graphpad Prism software).
Results
Excessive ER stress desensitized insulin receptor signaling As reported, the ER stress inducer tunicamycin significantly inhibited insulin signal transduction by suppression of insulininduced IRS-1 and AKT phosphorylation in Fao liver cells [3] . Here we examined the potential effects of tunicamycin on the insulin receptor in the HEK293 cell line. This cell line is often used as a model cell line in preliminary investigations related to ER stress, MAPK and insulin signaling path ways [20, 21] . Compared with the DMSO-treated group, short-term (2-4 h) stimulation with tunicamycin increased insulin-induced IR (Tyr1150/1151) phosphorylation. Prolonged tunicamycin treatment (8-12 h) attenuated such insulin-induced IR activities ( Figure 1A ). In addition, we also observed that the total amount of IR decreased after long-term tunicamycin treatment. These results indicate that short-term stimulation with tunicamycin could activate IR signaling, whereas excessive ER stress will desensitize this signaling in HEK293 cells.
ATF6 protected the insulin pathway from ER stress-induced desensitization ATF6 optimized long-term ER stress and protected cells from damage through regulating a number of genes responsible for protein folding and degradation [22] [23] [24] . Bearing that in mind, we thus investigated whether members of the ATF6 family could protect IR activity from excessive ER stress. For this assay, after transiently transfected with pcDNA3.1-ATF6α/ ATF6β, HEK293 cells were treated with tunicamycin for 4-12 h. The over-expression efficiency is shown in panels B and D of Figure 1 . As shown in panels C and E of Figure 1 , IR phosphorylation was highly responsive to insulin stimulation from 8 h in ATF6α-transfected cells and from 12 h in ATF6β-transfected cells. To further confirm that ATF6α/ ATF6β protection of IR phosphorylation in response to insulin induction only appeared under long-term ER stress stimulation, IR phosphorylation in ATF6α/ATF6β overexpressing cells without tunicamycin treatment were examined at 4, 8, and 12 h. As shown in Figure 1F , ATF6α/ATF6β overexpression failed to alter IR phosphorylation without tunicamycin treatment. Moreover, tunicamycin markedly decreased the total IR, while over expression of ATF6α (or ATF6β) failed to prohibit IR degradation ( Figure 1C and 1E) . To further verify this result, an ATF6α (or ATF6β) stable cell line with EYFP-C1 as a control was constructed and phosphorylation of IR was examined. The over-expression efficiency is shown in Figure  1G and 1I. As indicated in Figure 1H and 1J, obvious increase of IR phosphorylation induced by insulin was shown from 8-h tunicamycin stimulation in the ATF6α stable cell line and from 4-h tunicamycin supplementation in the ATF6β stable cell line. Compared with the transiently transfected cells, the protection of IR phosphorylation from degradation appeared at an earlier time in the ATF6 stable cell lines. This might be caused by a more efficient response to tunicamycin stimulation in stable cell lines with persistent ATF6 expression.
Therefore, all of our results suggest that the ATF6 family could protect IR activity from long-term ER stress stimulation, while such an effect may not be associated with the regulation of total IR protein level.
ATF6 protection against insulin resistance did not merely link with its function in ER stress ATF6 is one of the three main transducers in UPR that upregulate a series of genes to relieve the overload of unfolded protein in the ER, thus ameliorating long-term ER stress damage [24] [25] [26] [27] . Here, expression of three ATF6 target genes (GRP78, GRP94 and PDI) was examined in tunicamycin stimulated HEK293 stable cell lines. The results in Figure 2A -2D and Figure S1 indicate that the stable over-expressing ATF6α (or ATF6β) cells respond to tunicamycin stimulation potently as reflected by the increased expression levels of these genes as early as 4 h after stimulation. Additionally, we also examined whether the PERK-eIF2α and IRE1α-XBP-1 pathways could be modulated by ATF6 over-expression. As shown in Figure 2A and 2B, the PERK-phosphorylated eIF2α phosphorylation did not differ in the stable cells with ATF6α or ATF6β over-expres- Figure  2A , 2B, and 2E) at 12 h. These results are consistent with previously reported results [28] . Therefore, we propose that ATF6 function in the insulin pathway might be associated with resistance to ER stress. Considering that the cell death induced by ER stress could act as an assessment to evaluate sensitivity to ER stress [29] , we applied an MTT assay in stable ATF6α (or ATF6β) over-expressing cells. The results indicate that ATF6 over-expressing cells failed to counteract tunicamycin-induced cell death in HEK293 cells within 12 h ( Figure 2F) . Therefore, all of the above-mentioned results suggest that the regulation of the ATF6 family on IR activity might not solely depend on its modulation of UPR.
ATF6 failed to attenuate tunicamycin-induced JNK pathway activation As reported, the JNK pathway plays a central role in connecting ER stress with type 2 diabetes. Upon activation by ER stress through IRE1α [30] , JNK can directly phosphorylate IRS-1 at Ser307 leading to the reduction of insulin-induced IRS-1 tyrosine phosphorylation and a decrease in activity of the insulin pathway [31, 32] . Given that ATF6 might protect the insulin pathway by attenuating JNK pathway activity, the related ATF6 protection on IR phosphorylation from excessive tunicamycin stimulation is not connected with the p38 pathway Besides the JNK pathway, the MKK3/6-p38 and MEK1/2-ERK pathways are also associated with several key proteins within the insulin receptor signaling pathway (eg, IR, IRS, and AKT) [33] [34] [35] [36] [37] . We thereby hypothesized that the ERK or p38 pathways might be involved in ATF6's protection on insulin signaling from excessive ER stress stimulation. To evaluate this hypothesis, basal and insulin-stimulated p38 phosphorylation were tested in control or ATF6α transfected HEK293 cells with 4-12 h incubation with tunicamycin. An obvious increase in p38 phosphorylation was observed in ATF6α-transfected cells treated with tunicamycin. There were no apparent differences in p38 activity found between control and ATF6α transfected cells with insulin stimulation (Figures 3B and 3C ). In addition, SB203580 (specific p38 inhibitor) did not alter the phosphorylation of IR with long-term tunicamycin treatment -( Figure  3D ). These results indicate that the p38 signaling pathway might not contribute to the protective effects of ATF6. Similar results were also obtained by over-expressing ATF6β (data not shown).
ATF6 regulation against insulin receptor signaling is associated with the ERK pathway
To further explore the potential signaling pathway for ATF6 regulation of the insulin receptor, basal and insulin-stimulated ERK phosphorylation were tested in control or ATF6α transfected HEK293 cells incubated with tunicamycin for 0-24 h. The results indicate that insulin-stimulated ERK phosphorylation was significantly attenuated in cells exposed to tunicamycin at 12 h ( Figure 4A ), while its sensitivity in ATF6α-overexpressing cells maintained stability except with 24 h tunicamycin incubation ( Figure 4B ). Furthermore, the basal level of ERK phosphorylation was largely inhibited in ATF6α-overexpressing cells as compared with control cells ( Figure  4C) , whereas ATF6α was able to enhance the level of insulininduced ERK phosphorylation ( Figure 4D ) with tunicamycin treatment. Therefore, our findings demonstrate that ATF6 modulates ERK activity induced by tunicamycin stimulation.
To further confirm the role of ERK in ATF6 effects on IR, the IR activity was then evaluated in control and ATF6α transient transfected cells with or without U0126 (specific ERK inhibitor) treatment. As shown in Figure 5A , IR phosphorylation was greatly dampened by long-term tunicamycin incubation in control but not in ATF6α transient transfected cells. As expected, U0126 treatment almost completely inhibited ERK activity and restored the insulin-stimulated IR phosphorylation in control cells. On the contrary, epidermal growth factor (EGF, ERK activator) treatment together with tunicamycin stimulation largely decreased the protective effects of ATF6α on IR ( Figure 5B ). However, the results shown in Figure 5C are without tunicamycin treatment and suggest that the above ERK-associated hypothesis was tenable under the instance of tunicamycin stimulation. Similar results were also obtained by over-expressing ATF6β (data not shown). Accordingly, our results imply that ATF6 protects IR activity through attenuation of basal ERK activity (at 4-12 h) that is subject to excessive ER stress stimulation.
Discussion
In recent years, accumulating evidence has demonstrated that the ER may serve as an "interpreter" by sensing a number of exogenous or endogenous stimuli such as inflammatory cytokines [38, 39] , abnormal energy fluxes [15] and oxidative stimuli [40] . The ER is a complicated and systemic network, and excessive ER stress may result in insulin resistance [3, 41, 42] and islet β-cell dysfunction [43] . Currently, increasing chaperones has been reported to help improve insulin resistance [6] . Here we focused on ATF6 for its potent service as a critical signal transducer in the ER stress system. ATF6 is responsible for up-regulating main chaperone systems [27] and plays a pivotal role in XBP-1 generation [44] , which is essential to normal insulin signaling pathway functioning and glucose homeostasis [3] . In addition, the genetic report has even identified ATF6 as a susceptibility gene of type 2 diabetes in Pima Indians [45] . As previously published [43, 46] , short-term (from 0 to 4 h) ER stress stimulation could increase AKT activity, while long-term (from 8 to 12 h) stimulation could suppress AKT activity. This reflects the dual character of ER stress: the adaptive/moderate level stress (featured by increased chaperone proteins and decreased misfolded proteins) and the destructive/excessive level stress (featured by activating JNK, apoptosis signal-regulating kinase (ASK)) [2, 3, 30, 47] . We found that tyrosine-phosphorylated IR was first elevated and then decreased when stimulated with tunicamycin, while total IR decreased after tunicamycin incubation ( Figure 1A ) based on the results of p-IR/GAPDH ratio quantification instead of the p-IR/t-IR ratio because t-IR was too weak to quantify in 12 h. IR is an important upstream regulator of AKT and its change may partly account for the variation of AKT activity. We discovered that the ATF6 family could protect IR activity from tunicamycin stimulation. To further investigate whether ATF6 protection on IR could affect its downstream molecules, phosphorylation of AKT was examined. As shown in Figure  S2 , ATF6 also protects AKT from phosphorylation degradation induced by tunicamycin.
The contribution of ER stress transducer and related genes were evaluated in HEK293 cell lines to investigate the mechanism of ATF6 protection on the insulin pathway. Although the phosphorylation of IRE1α and cleavage of ATF6 could be modulated in ATF6 over-expressing cells, we failed to find any differences between ATF6 over-expression and control cells in the MTT assay. These results suggest that ATF6 overexpression does not improve cell sensitivity to ER stress and regulation of the ATF6 family on IR activity might not be dependent on its protective roles in ER stress. Recently, more new target genes of the ATF6 family have been discovered, including ER-stress related genes (eg, GRP78, GRP94, PDI, XBP-1 [21] ) and others [eg, Sterol regulatory element binding protein 2 (SREBP2) [48] ]. It is reported that 250 genes could be up-regulated by tunicamycin treatment and at least 45 were ATF6α-dependent, although most of these genes have not yet been fully investigated [23] . The MAPK signaling pathways MKK4/7-SAPK/JNK, MKK3/6-p38, and MEK1/2-ERK have been reported to play key roles in insulin resistance induced by excessive ER stress [33] [34] [35] [36] [37] [38] . Therefore, the phosphorylation of JNK, p38 and ERK were examined in ATF6 over-expressing cells. Our results indicate that the MEK1/2-ERK pathway is associated with the ATF6 protection mechanism. Before our investigation, several studies reported that MEK exerted negative effects on the insulin signaling pathway via down-regulation [33] [34] [35] . Several diabetes-inducing agents have also been demonstrated as causing insulin resistance in a MEK-dependent manner [35, 20] . ER stress was also reported to induce activation of ERK [46] , and ATF6 was shown to counteract the effects of ER stress [23, 24] . Based on this prior evidence and our results (Figures 4 and 5) , it could be concluded that excessive ER stress could increase the basal, but decrease the insulin-induced, activity of ERK. We thus propose the potential effects of ATF6 to be as follows. Long-time ER stress stimulation could induce a constant "basal" activation of the ERK pathway, which might have a negative feedback causing the desensitization of IR activity. ATF6 could counteract this negative process through downregulation of the basal ERK activity and up-regulation of insulin-induced ERK activity until 12 h, leading to the restoration of insulin signaling pathway activity. Although our results also showed that ATF6 could enhance p38 activity, it seems that p38 is not involved in ATF6 modulation of IR phosphorylation ( Figure 3 ). This is consistent with the finding that p38 stimulates insulin-induced glucose uptake through GLUT4 activation instead of IR/IRS/AKT-dependent transporter translocation [36, 37] . As reported, ATF6 family members exhibit different influences on GRP78 transcription with a hypothetical mechanism that ATF6α, as a strong but labile transcription factor, and ATF6β, as a weak but stable transcription factor, work collaboratively to address different ER stress signals [11, 12] . However, we found that ATF6α and ATF6β demonstrated almost the same effects on IR activity. Thus, we hypothesized that no matter what characteristics they possess, these two isotypes might have similar influences on ER quality and cellular physiology in the process of adaptation to long-time stress since chronic stimulation would fully induce their activities.
Contrary to the opinion that the ATF6 family contributes to alleviating cellular stress [9, 16, 24] , the studies by Seo et al suggest that ATF6 plays an important role in the development of β-cell dysfunction [49] . Although ATF6 was shown to suppress insulin gene expression in INS-1 cells, this process might be a feedback to prevent hyperinsulinmia in vivo. In addition, this report also indicated that ATF6 expression was increased in the pancreatic islets of diabetic rats compared with nondiabetic counterparts. However, this study did not confirm that the increase in ATF6 expression might cause or aggregate diabetes. Based on our current work, we suggest that ATF6 family members could be up-regulated in response to cellular stress to counteract the diabetic stress.
Recently, more studies have suggested that the signaling pathway involved in ER stress could be used as a potential target for anti-type 2 diabetes drug design [4-6, 38, 39] . Here we discovered that ATF6 family members protect the insulin receptor pathway from long-term tunicamycin treatment (4-12 h) that mimics the effects of chronic ER stress, implying that ATF6 could be a potential target for increasing insulin sensitivity. However, further investigations need to be carried out to clarify the underlying mechanism by which ATF6 regulates ERK activity and other diabetes-related pathways.
